Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Investigative Radiology"
DOI: 10.1097/rli.0000000000000697
Abstract: Supplemental digital content is available in the text. Objectives Early detection of pancreatic ductal adenocarcinoma (PDAC) represents the most significant step toward the treatment of this aggressive lethal disease. Previously, we engineered a preclinical Thy1-targeted… read more here.
Keywords: pdac; contrast agent; scfv; thy1 targeted ... See more keywords